|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
| Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
| ClinicalTrials.gov Identifier: | NCT00006310 |
Purpose
To determine the seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in blood donors from Texas. Also to examine the donors' demographic characteristics and to characterize the KSHV using polymerase chain reaction.
| Condition |
|
Blood Donors Acquired Immunodeficiency Syndrome Blood Transfusion Herpesvirus, Kaposi Sarcoma-Associated Sarcoma, Kaposi HIV Infections |
| MedlinePlus related topics: | AIDS Blood Transfusion and Donation Kaposi's Sarcoma Soft Tissue Sarcoma |
| Study Type: | Observational |
| Study Design: | Natural History |
Eligibility
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
No eligibility criteria
Contacts and Locations
More Information
| Study ID Numbers: | 918 |
| First Received: | September 28, 2000 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00006310 |
| Health Authority: | United States: Federal Government |
|
|
|
|